Market Value6,459,165,358
Total Holdings68
File Date2024-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RNA / Avidity Biosciences, Inc.
PTGX / Protagonist Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
OBIO / Orchestra BioMed Holdings, Inc.
ETNB / 89bio, Inc.
GHRS / GH Research PLC
ACAD / ACADIA Pharmaceuticals Inc.
APGE / Apogee Therapeutics, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
BRKR / Bruker Corporation
RCKT / Rocket Pharmaceuticals, Inc.
INSM / Insmed Incorporated
NTRA / Natera, Inc.
SYRE / Spyre Therapeutics, Inc.
PCSC / Perceptive Capital Solutions Corp
SYK / Stryker Corporation
DYN / Dyne Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
CYTK / Cytokinetics, Incorporated
URGN / UroGen Pharma Ltd.
MASI / Masimo Corporation
STOK / Stoke Therapeutics, Inc.
ALUR / Allurion Technologies Inc.
ARYD / ARYA Sciences Acquisition Corp IV
LRMR / Larimar Therapeutics, Inc.
ROIV / Roivant Sciences Ltd.
TRML / Tourmaline Bio, Inc.
SLRN / Acelyrin, Inc.
RGNX / REGENXBIO Inc.
EPIX / ESSA Pharma Inc.
GKOS / Glaukos Corporation
AKRO / Akero Therapeutics, Inc.
TXG / 10x Genomics, Inc.
MRUS / Merus N.V.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
CGON / CG Oncology, Inc.
ARVN / Arvinas, Inc.
IMTX / Immatics N.V.
ABIO / ARCA biopharma, Inc.
SGMT / Sagimet Biosciences Inc.
VCEL / Vericel Corporation
ISRG / Intuitive Surgical, Inc.
NGNE / Neurogene Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
ACET / Adicet Bio, Inc.
CTMX / CytomX Therapeutics, Inc.
RDNT / RadNet, Inc.
ALKS / Alkermes plc
JANX / Janux Therapeutics, Inc.
AVADEL PHARMACEUTICALS PLC / SPONSORED ADR (05337M104)
SWAV / Shockwave Medical, Inc.
EXAS / Exact Sciences Corporation
TMO / Thermo Fisher Scientific Inc.
IMUX / Immunic, Inc.
KYTX / Kyverna Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
VRDN / Viridian Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
SABS / SAB Biotherapeutics, Inc.
REPL / Replimune Group, Inc.
TSHA / Taysha Gene Therapies, Inc.
CGEM / Cullinan Therapeutics, Inc.
XAIR / Beyond Air, Inc.
PEN / Penumbra, Inc.
XGN / Exagen Inc.
TEM / Tempus AI, Inc.
LENZ / LENZ Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
CUTRQ / Cutera, Inc.
CRGX / CARGO Therapeutics, Inc.
PTCT / PTC Therapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
MIST / Milestone Pharmaceuticals Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)